| Patents for C07K 1 - General processes for the preparation of peptides (51,718) |
|---|
| 06/07/2006 | EP1666646A1 Protein crystallization apparatus, method of protein crystallization, protein crystallizing agent and process for preparing the same |
| 06/07/2006 | EP1666591A1 Cytokine that induces apoptosis |
| 06/07/2006 | EP1666487A1 Purification of hbv antigens for use in vaccines |
| 06/07/2006 | EP1666047A1 Pharmaceutical compositions comprising nitric oxide-releasing pyrrolidones |
| 06/07/2006 | EP1664398A2 Methods and apparatus for rapid crystallization of biomolecules |
| 06/07/2006 | EP1664320A2 Acyltransferases for alteration of polyunsaturated fatty acids and oil content in oleaginous yeasts |
| 06/07/2006 | EP1664110A1 A continuous process for the assembly of macromolecular substances and the subsequent capture and isolation of a macromolecular assembly, and a system suitable for the process |
| 06/07/2006 | EP1664108A1 Separation of polypeptides comprising a racemized amino acid |
| 06/07/2006 | EP1664088A2 Hemiasterlin derivatives and uses thereof |
| 06/07/2006 | EP1664087A1 Prion clearance using particulate metal oxides |
| 06/07/2006 | EP1664085A1 Detecting molecules |
| 06/07/2006 | EP1664083A1 Method for preparing polyfunctionalized peptides and/or proteins via native chemical ligation |
| 06/07/2006 | EP1664081A2 Novel proteins and nucleic acids encoding same |
| 06/07/2006 | EP1663298A2 Use of proline specific endoproteases to hydrolyse peptides and proteins |
| 06/07/2006 | EP1663275A2 Stationary phases and a purification process using the stationary phases |
| 06/07/2006 | EP1663110A2 Uses of interferons with altered spatial structure |
| 06/07/2006 | EP1585758A4 Peptides having protected amines of untargeted sites, methods for production thereof and of specifically conjugated peg peptides using the same |
| 06/07/2006 | EP1534718A4 Chemical synthesis of reagents for peptide coupling |
| 06/07/2006 | EP1434493B1 Flax protein isolate and production |
| 06/07/2006 | EP1315738A4 Extended native chemical ligation |
| 06/07/2006 | EP1313849B1 Methods for producing cloned avians |
| 06/07/2006 | EP1268514B1 Methods for purifying highly anionic proteins |
| 06/07/2006 | EP1147127B1 Volatilizable solid phase supports for compound synthesis |
| 06/07/2006 | CN1784493A Modified beta-lactamases and uses thereof |
| 06/07/2006 | CN1258537C Method for preparing polypeptide soluble in aqueous solvent in absence of detergent |
| 06/06/2006 | US7057020 Isolated RuvB polypeptides |
| 06/06/2006 | US7057019 Crosslinked albumin hydrogels |
| 06/06/2006 | US7057018 Pro 1474 polypeptides |
| 06/06/2006 | US7057016 Process for the production of biologically active protein |
| 06/06/2006 | US7057014 dissolving nonapeptides/decapeptides (luteinizing hormone-releasing hormone antagonists) in solvent mixture comprising water and alcohol (methanol), stirring with methyl acetate, preciptating, washing, then drying |
| 06/06/2006 | US7056691 Assays for identifying α-galactosidases |
| 06/06/2006 | US7056666 Labeling a terminal monomer and scanning to determine the position; can analyze hundreds of macromolecules simultaneously |
| 06/06/2006 | US7056516 Comprises nucleotide sequences coding caspase 8 inhibitory protein for use in the treatment of alzheimer's, parkinson's, arthritic, septic, cardiovascular, inflammatory, osteoporotic and ischemic reperfusion injuries/disorders |
| 06/06/2006 | US7056514 Partial peptide mimetics and methods |
| 06/06/2006 | US7056513 Peptides for use in the treatment of cancer and aging |
| 06/06/2006 | US7056508 Receptor-type phosphotyrosine phosphatase-kappa antibodies |
| 06/06/2006 | US7056507 Adsorbent for eliminating hepatitis C virus, adsorber, and adsorption method |
| 06/06/2006 | US7056426 Placing a gel-forming liquid mixture comprising acrylamide monomer, crosslinking agent, buffer, and nonionic amphiphilic polymer in aqueous solution inside enclosure defined by inert, transparent plates; addition polymerization |
| 06/06/2006 | CA1341506C Factor viii coagulant polypeptides and monoclonal antibodies to them |
| 06/01/2006 | WO2006056575A1 Purification of recombinant human factor xiii |
| 06/01/2006 | WO2006056484A1 Protein isolation and purification |
| 06/01/2006 | WO2006039163A3 Cyclosporin alkyne analogues and their pharmaceutical uses |
| 06/01/2006 | WO2006037931A3 Method for extracting protein for separating same |
| 06/01/2006 | WO2005124647A3 Isolation and purification of biochemicals |
| 06/01/2006 | WO2005121178A3 Immunoaffinity chromatography polyol-responsive monoclonal antibodies |
| 06/01/2006 | WO2005058941A3 Aβ IMMUNOGENIC PEPTIDE CARRIER CONJUGATES AND METHODS OF PRODUCING SAME |
| 06/01/2006 | WO2005019426A3 Gene cluster for fostriecin biosynthesis |
| 06/01/2006 | WO2005001025A3 Immunoglobulin chimeric monomer-dimer hybrids |
| 06/01/2006 | US20060116507 Osteogenic devices |
| 06/01/2006 | US20060116322 Formation of novel erythropoietin conjugates using transglutaminase |
| 06/01/2006 | US20060115813 Intracellular signaling molecules |
| 06/01/2006 | US20060113190 Microfluidic device and method for improved sample handling |
| 06/01/2006 | US20060113189 Method for separating substances |
| 06/01/2006 | DE102004056980A1 Verfahren zur ortsspezifischen Synthese von Biopolymeren auf festen Trägern A method for site-specific synthesis of biopolymers on solid supports |
| 06/01/2006 | CA2630475A1 Mer diagnostic and therapeutic agents |
| 06/01/2006 | CA2589158A1 Protein isolation and purification |
| 06/01/2006 | CA2587139A1 Purification of recombinant human factor xiii |
| 05/31/2006 | EP1661906A1 Method of preparing solution having composition of biological components |
| 05/31/2006 | EP1661566A2 Use of beta-sheet mimetics as protease and kinase inhibitors and as inhibitors of transcription factors |
| 05/31/2006 | EP1660678A2 Mutant adeno-associated virus virions and methods of use thereof |
| 05/31/2006 | EP1660517A2 Nogo receptor antagonists |
| 05/31/2006 | EP1660206A1 Methods and kits for purifying his-tagged proteins |
| 05/31/2006 | EP1659919A2 Hemostatic devices containing a protein precipitate |
| 05/31/2006 | EP1165110B1 Antagonists of hmg1 for treating inflammatory conditions |
| 05/31/2006 | EP1105410A4 Purification of blood clotting proteins |
| 05/31/2006 | EP1001028B1 Gene encoding protein having aurone synthesizing activity |
| 05/31/2006 | EP0911342B1 Novel protein and process for producing the same |
| 05/31/2006 | CN1780850A Use of lectins to promote oligomerization of glycoproteins and antigenic molecules |
| 05/31/2006 | CN1778929A Recombinant human platelet auxin/dry cell factor fusion protein and preparation thereof |
| 05/31/2006 | CN1778821A Granular leukocyte colony-stimulating factors coupling agent with chemical modification and production thereof |
| 05/30/2006 | US7053185 contacting alpha-lactalbumin (in molten globule-like state) with fatty acids and lipids found in a milk fraction containing casein obtained from humans; antibacterial agents; anticancer agents |
| 05/30/2006 | US7053184 Expression vector coding polypeptide with thrombin proteolytic sequences; for use in evaluating ligand binding and signal transduction |
| 05/30/2006 | US7053054 Purified LH |
| 05/30/2006 | US7053047 Cyclic pentapeptides and their preparation |
| 05/30/2006 | US7052916 Polypeptide analyses using stable isotope labeling |
| 05/30/2006 | US7052915 Selective labeling and isolation of phosphopeptides and applications to proteome analysis |
| 05/30/2006 | US7052892 For preventing, ameliorating, disorders or diseases including cancer, peripheral and central nervous system disorders, genitourinary disorders, cardiovascular disorders, and Chronic obstructive pulmonary (or airways) disease (COPD) |
| 05/30/2006 | US7052869 Obtaining a consensus protein from a group of amino acid sequences of a defined protein family |
| 05/30/2006 | US7052704 Comprises fatty acid-conjugated products with disulfide linkage to proteins/peptides for delivery to cells; increases absorption and prolongs blood and tissue retention |
| 05/26/2006 | WO2006055264A1 Formulations, methods of production and uses of fgf-20 |
| 05/26/2006 | WO2005115478A3 Methods and compositions for autism spectrum disorders |
| 05/26/2006 | WO2004084835A3 Treating immunological disorder using agonists of interleukin-21/ interleukin-21 receptor |
| 05/26/2006 | CA2586213A1 Formulations, methods of production and uses of fgf-20 |
| 05/25/2006 | WO2006032457A9 Peptide cyclisation |
| 05/25/2006 | US20060111558 Recombinant infectious laryngotracheitis virus and uses thereof |
| 05/25/2006 | US20060111277 treating fungal infections; improved thermal stability and water solubility; releasing carbohydrate upon dispersion of the complex in water |
| 05/25/2006 | US20060110777 Structured peptide scaffold for displaying turn libraries on phage |
| 05/25/2006 | US20060108224 Rapid flow fractionation of particles combining liquid and particulate dielectrophoresis |
| 05/24/2006 | EP1659398A1 Verfahren zur Analyse von Hämoglobin durch Kapillarelektrophorese, Besteck für die Kapillarelektrophorese und Verwendung eines Strömungsverlangsamers in einem solchen Verfahren |
| 05/24/2006 | EP1659179A2 Tumor-associated antigen derivatives from the mage family, and nucleic acid sequences encoding them, used for the preparation of fusion proteins and of compositions for vaccination |
| 05/24/2006 | EP1659178A2 Tumor-associated antigen derivatives from the mage family, and nucleic acid sequences encoding them, used for the preparation of fusion proteins and of compositions for vaccination |
| 05/24/2006 | EP1658506A2 Methods for reducing complexity of a sample using small epitope antibodies |
| 05/24/2006 | EP1509390A4 Carbon nanotube binding peptides |
| 05/24/2006 | EP1419277B1 Isolation of membrane bound ligand-specific complexes |
| 05/24/2006 | EP1227848B1 Method for linking molecular substances |
| 05/24/2006 | EP1200179B1 Charged filtration membranes and uses therefor |
| 05/24/2006 | EP1169648B1 Use of 13c-nmr to detect binding |
| 05/24/2006 | EP0892809B1 Fhit proteins and nucleic acids and methods based thereon |
| 05/24/2006 | CN1777443A Methods of diagnosing and treating pre-eclampsia or eclampsia |
| 05/24/2006 | CN1777435A Method of purifying polypeptides by simulated moving bed chromatography |